National Comprehensive Cancer NetworkJun 26 2024 The National Comprehensive Cancer Network® -;a nonprofit alliance of leading cancer centers-;is publishing new results for its latest survey on cancer drug shortages in the United States. This follows data published one year ago, and six months ago, illustrating how up to 93% of centers surveyed were experiencing shortages of the crucial chemotherapy carboplatin at its peak.
The ongoing drug shortages were also found to affect clinical trials at 43% of centers by impacting budgeting, enrollment, and raising administrative burden. 27% reported treatment delays due to shortage-related changes that required additional prior authorization. The responding centers continue to mitigate the impact of shortages through a combination of strategies, including waste reduction management plus adjusted timing and dosage within evidence-based ranges.
Source: Healthcare Press (healthcarepress.net)
Cancer Treatment Carboplatin Chemotherapy Cisplatin Education Manufacturing Oncology Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: MENnewsdesk - 🏆 23. / 69 Read more »
Source: SkyNews - 🏆 35. / 67 Read more »
Assange’s bail hearing requested to be private ‘for US national security’The plea agreement between the US and Julian Assange was signed on June 19 and a bail hearing was heard in private the next day.
Source: Glasgow_Times - 🏆 76. / 59 Read more »